BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Evaxion Biotech

Evaxion Biotech logo

Founded
2008
Patents
27
Clinical Trials
2
Publications
16

Technologies

AI Companies (Drug Discovery)

Using cutting-edge immunology, bioinformatics, and machine learning methods, Evaxion Biotech is discovering and developing 'best in class’ vaccines for infectious diseases and cancer at an unprecedented rate. We have constructed a robust product engine for the development of novel vaccines and therapies based on our two platforms, PIONEER and EDEN. Using state of the art in silico tools, the platforms integrate big data, artificial intelligence and supercomputing to predict, rank and optimize epitopes and antigens that elicit a highly protective immune response against cancers and infectious diseases. EDEN enables rapid and accurate discovery of novel antigens that elicit a highly cross-protective immune response in any bacterial pathogen while PIONEER has been constructed to identify the epitopes of mutated proteins that will fire up the body’s natural immune responses to them.

Become a Member to view additional information about this company

Posts Mentioning This Company

Video gallery